Cargando…

Compatibility of a Novel Thrombospondin-1 Analog with Fertility and Pregnancy in a Xenograft Mouse Model of Endometriosis

Endometriosis is a gynecological disease defined by the growth of endometrium outside of the uterus. Although endometriosis contributes to 50% of female infertility cases, medical treatments are incompatible with pregnancy. Angiogenesis, the growth of blood vessels from existing vasculature, plays a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Diane S., Edwards, Andrew K., Ahn, Soo Hyun, Thomas, Richard, Tayade, Chandrakant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374840/
https://www.ncbi.nlm.nih.gov/pubmed/25811892
http://dx.doi.org/10.1371/journal.pone.0121545
_version_ 1782363553207943168
author Nakamura, Diane S.
Edwards, Andrew K.
Ahn, Soo Hyun
Thomas, Richard
Tayade, Chandrakant
author_facet Nakamura, Diane S.
Edwards, Andrew K.
Ahn, Soo Hyun
Thomas, Richard
Tayade, Chandrakant
author_sort Nakamura, Diane S.
collection PubMed
description Endometriosis is a gynecological disease defined by the growth of endometrium outside of the uterus. Although endometriosis contributes to 50% of female infertility cases, medical treatments are incompatible with pregnancy. Angiogenesis, the growth of blood vessels from existing vasculature, plays a crucial role in endometriotic lesion growth and survival. Previously, we demonstrated the effectiveness of thrombospondin-1 analog, ABT-898 (Abbott Laboratories) to inhibit endometriotic lesion vascularization in mice. We have now evaluated the trans-generational implications of ABT-898 treatment before and during mouse pregnancy. We hypothesized that ABT-898 would target lesion vasculature without affecting pregnancy, offspring development, or ovarian and uterine vascularity in mice. Endometriosis was induced using human endometrium in β-estradiol-primed BALB/c-Rag-2(-/-)Il2rγ(-/-) mice receiving intraperitoneal injections of ABT-898 (25 mg/kg) or 5% dextrose control for 21 days. Ultrasound assessment of lesion vascularization revealed a reduction in blood flow supplying treated lesions. Excised ABT-898 treated lesions stained for CD31(+) endothelial cells exhibited a decrease in microvessel density. Following confirmation of estrous cycling, mice were bred and treated with ABT-898 on gestation days 7, 9, 11, 13, 15, 17, and 19. ABT-898 did not affect estrous cycling or pregnancy parameters including litter size across generations and offspring weight gain. Quantification of angiogenic cytokine plasma levels revealed no significant differences between treatment groups. Vimentin staining of the uterus and ovary revealed no observable effects of ABT-898. Similarly, no obvious histological anomalies were observed in the kidney, liver, ovary, or uterus following ABT-898 treatment. These results suggest that ABT-898 effectively inhibit endometriotic lesion vascularization without affecting trans-generational pregnancy outcomes in mice.
format Online
Article
Text
id pubmed-4374840
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43748402015-04-04 Compatibility of a Novel Thrombospondin-1 Analog with Fertility and Pregnancy in a Xenograft Mouse Model of Endometriosis Nakamura, Diane S. Edwards, Andrew K. Ahn, Soo Hyun Thomas, Richard Tayade, Chandrakant PLoS One Research Article Endometriosis is a gynecological disease defined by the growth of endometrium outside of the uterus. Although endometriosis contributes to 50% of female infertility cases, medical treatments are incompatible with pregnancy. Angiogenesis, the growth of blood vessels from existing vasculature, plays a crucial role in endometriotic lesion growth and survival. Previously, we demonstrated the effectiveness of thrombospondin-1 analog, ABT-898 (Abbott Laboratories) to inhibit endometriotic lesion vascularization in mice. We have now evaluated the trans-generational implications of ABT-898 treatment before and during mouse pregnancy. We hypothesized that ABT-898 would target lesion vasculature without affecting pregnancy, offspring development, or ovarian and uterine vascularity in mice. Endometriosis was induced using human endometrium in β-estradiol-primed BALB/c-Rag-2(-/-)Il2rγ(-/-) mice receiving intraperitoneal injections of ABT-898 (25 mg/kg) or 5% dextrose control for 21 days. Ultrasound assessment of lesion vascularization revealed a reduction in blood flow supplying treated lesions. Excised ABT-898 treated lesions stained for CD31(+) endothelial cells exhibited a decrease in microvessel density. Following confirmation of estrous cycling, mice were bred and treated with ABT-898 on gestation days 7, 9, 11, 13, 15, 17, and 19. ABT-898 did not affect estrous cycling or pregnancy parameters including litter size across generations and offspring weight gain. Quantification of angiogenic cytokine plasma levels revealed no significant differences between treatment groups. Vimentin staining of the uterus and ovary revealed no observable effects of ABT-898. Similarly, no obvious histological anomalies were observed in the kidney, liver, ovary, or uterus following ABT-898 treatment. These results suggest that ABT-898 effectively inhibit endometriotic lesion vascularization without affecting trans-generational pregnancy outcomes in mice. Public Library of Science 2015-03-26 /pmc/articles/PMC4374840/ /pubmed/25811892 http://dx.doi.org/10.1371/journal.pone.0121545 Text en © 2015 Nakamura et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Nakamura, Diane S.
Edwards, Andrew K.
Ahn, Soo Hyun
Thomas, Richard
Tayade, Chandrakant
Compatibility of a Novel Thrombospondin-1 Analog with Fertility and Pregnancy in a Xenograft Mouse Model of Endometriosis
title Compatibility of a Novel Thrombospondin-1 Analog with Fertility and Pregnancy in a Xenograft Mouse Model of Endometriosis
title_full Compatibility of a Novel Thrombospondin-1 Analog with Fertility and Pregnancy in a Xenograft Mouse Model of Endometriosis
title_fullStr Compatibility of a Novel Thrombospondin-1 Analog with Fertility and Pregnancy in a Xenograft Mouse Model of Endometriosis
title_full_unstemmed Compatibility of a Novel Thrombospondin-1 Analog with Fertility and Pregnancy in a Xenograft Mouse Model of Endometriosis
title_short Compatibility of a Novel Thrombospondin-1 Analog with Fertility and Pregnancy in a Xenograft Mouse Model of Endometriosis
title_sort compatibility of a novel thrombospondin-1 analog with fertility and pregnancy in a xenograft mouse model of endometriosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374840/
https://www.ncbi.nlm.nih.gov/pubmed/25811892
http://dx.doi.org/10.1371/journal.pone.0121545
work_keys_str_mv AT nakamuradianes compatibilityofanovelthrombospondin1analogwithfertilityandpregnancyinaxenograftmousemodelofendometriosis
AT edwardsandrewk compatibilityofanovelthrombospondin1analogwithfertilityandpregnancyinaxenograftmousemodelofendometriosis
AT ahnsoohyun compatibilityofanovelthrombospondin1analogwithfertilityandpregnancyinaxenograftmousemodelofendometriosis
AT thomasrichard compatibilityofanovelthrombospondin1analogwithfertilityandpregnancyinaxenograftmousemodelofendometriosis
AT tayadechandrakant compatibilityofanovelthrombospondin1analogwithfertilityandpregnancyinaxenograftmousemodelofendometriosis